A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Who Are Treated With Tocilizumab
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 29 May 2014
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 May 2014 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 09 Sep 2013 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
- 09 Sep 2013 Planned number of patients changed from 50 to 20 as reported by ClinicalTrials.gov record.